Abstract:
PURPOSE: A nanocapsule is provided to maintain and improve physical stability in vivo and to encapsulate a material(insoluble drub and/or contrast agent). CONSTITUTION: A nanocapsule comprises an inner core and a shell surrounding the inner core. The shell is prepared by covalent bond of a non-ionic polymer and albumin. A method for manufacturing the nanocapsule comprises: a step of dissolving a non-ionic polymer in an organic solvent and preparing an oil-in-water emulsion; a step of treating the emulsion by ultrasonic wave and crosslinking albumin by covalent bond; and a step of evaporating remaining inorganic solvent. [Reference numerals] (AA) Organic solvent in which non-ionic polymer is dissolved with rarely soluble drug, a contrast medium, and others; (BB) Water with dissolved water soluble polymer; (CC) Oil-in-water emulsion; (DD) Crosslinking(pH 9); (EE) Organic solvent evaporating process; (FF) Water soluble polymer; (GG) Non-ionic polymer; (HH) Polymer nanocapsule containing rarely soluble drug and contrast medium; (II) Non-ionic polymer A-(X)_n; (JJ) Water soluble polymer B-(Y)_n; (KK) Rarely soluble drug, contrast medium
Abstract:
본 발명에 따른 약물방출 풍선 카테터는 풍선 표면에 약물봉입 미세입자 및 생체적합성 고분자가 순차적 및 반복적으로 다층 코팅된 약물방출 풍선 카테터로서, 혈액의 정상 산도인 pH 7.4에서 가장 높은 약물방출량을 나타내고, 혈관 내에서 시술 부위까지 이동하는 동안 약물의 손실이 거의 없으며, 시술 부위에서 풍선 카테터를 팽창시킴으로써 부위 특이적(site-specific)으로 단시간 내에 약물을 다량 방출할 수 있고, 원하는 시술부위에서 풍선을 팽창시켰을 때 초기 약물 방출량이 매우 우수하므로, 관상동맥 질환 및 협착성 질환의 시술용 기구로 사용할 수 있다.
Abstract:
본 발명은 (a) 내부 코어(inner core); 및 (b) 상기 내부 코어를 포위하는 쉘(shell)을 포함하는 나노캡슐(nano capsule)로서, 상기 쉘(shell)은 기능기가 도입된 비이온성 고분자 및 알부민이 공유결합에 의한 가교가 형성되어 이루어지는 것을 특징으로 하는 나노 캡슐(nano capsule) 및 상기 나노 캡슐의 제조 방법에 관한 것이다. 종래 고분자 마이셀과 리포좀과는 달리, 본 발명의 나노 캡슐은 생체 내에서 물리적 안정성을 유지 및 개선시키고, 운반 대상(예컨대, 난용성 약물 및/또는 조영제 등)을 고효율로 봉입할 수 있다. 또한 기존의 발명에서 오일 및 유기 용매를 이용하여 난용성 물질을 운반한 것과 달리, 오직 치료에 필요한 운반 대상만을 포함하여 나노캡슐을 제조할 수 있다. 따라서, 본 발명의 나노 캡슐은 주사제 제형으로 유용하게 이용할 수 있고, 난용성 약물 및/또는 조영제를 운반 대상으로 봉입하여 생체 내 약물 치료 및/또는 이미징에 이용될 수 있다.
Abstract:
PURPOSE: A chemical eluting balloon catheter multilayer-coated with chemical sealing fine particles and polymer and a method for preparing the same are provided to minimize the loss of chemical while transferring from a blood vessel to a surgical region. CONSTITUTION: A chemical eluting balloon catheter includes chemical sealing fine particles and biocompatible polymer. The fine particles and the polymer are multilayer coated on the surface of the balloon catheter. The diameters of the fine particles are less than or equal to 5um. The polymer is one or more selected from heparin, recombinant heparin, heparin derivative, heparin analogue, human serum albumin, hyaluronic acid, chitosan, alginic acid, deoxyribonucleic acid, ribonucleic acid, poly(ethylene glycol), poly(L-lactic acid), poly(glycolic acid), poly(D,L- lactic acid-co-glycolic acid), poly(carprolactone), poly(urethane), poly(amide), polymethylmethacrylate, and poly(acrylic acid). A chemical elution adjusting membrane is further coated on the uppermost layer of the multilayered coating.
Abstract:
Hydrophilic polymer nanocapsules are provided to encapsulate poorly soluble drugs, contrast mediums, oils, etc. stably and highly efficiently by cross-linking carious natural and synthetic hydrophilic polymers by covalent bond, and a method for preparing the hydrophilic polymer nanocapsules is provided. A method for preparing a hydrophilic polymer nanocapsule comprises the steps of: (a) dissolving a poorly soluble drug and a nonionic polymer into an organic solvent to obtain a stable oil-in-water emulsion; (b) subjecting a water phase-solubilized hydrophilic polymer to a cross-linking reaction by covalent bond on an interface of the obtained oil-in-water emulsion; and (c) evaporating a residual organic solvent to remove the residual organic solvent after performing the cross-linking reaction. The organic solvent is selected from the group consisting of methylene chloride, chloroform, 1,2-dichloroethane, cyclohexane, methyl ether ketone, butylacetate, and ethylacetate. The method further comprises the step of dissolving a contrast medium and oil into the organic solvent in the step(a). The nonionic polymer is represented by the formula A-(X)n, where A is a polymer chain that has hydrophilicity and hydrophobicity at the same time and can be solubilized into a water phase and an oil phase, X is a functional group introduced into the polymer chain A and bonded to a functional group of the hydrophilic polymer by covalent bond, and n is an integer of 2 to 1,000 as the number of the functional groups X introduced per one molecule of the polymer chain A.